Reveladerm's formulation is built on three pillars: purity, concentration, and bioavailability. Each pillar reflects a deliberate choice by a physician-led team committed to clinical rigor in topical skincare.
A 14-day dermatologist-supervised observational evaluation reported improvement in the appearance of erythema in 71% of analyzed patients applying Reveladerm twice daily. Erythema appearance was evaluated using standardized dermatologic assessment protocols.
Evidence architecture
- FDA cGMP manufacturing with full chain-of-custody
- Third-party Certificate of Analysis on every batch
- Dermatologist-supervised observational evaluation
- 17 documented case observations across diverse skin presentations
Enable JavaScript to view the full site.